LAS VEGAS — Use of a bioconvertible inferior vena cava filter successfully prevented new-onset pulmonary embolism in high-risk patients and was bioresorbed within 1 year in most cases, according to ...

BOTHELL, Wash.--(BUSINESS WIRE)--BTG plc (LSE: BTG), the global healthcare company, highlighted the presentation of the two-year results for the SENTRY trial, at the Vascular Interventional Advances ...

in reducing potential complications seen with conventional filters.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. LAS VEGAS — Use of a bioconvertible inferior vena cava ...

If you have had a deep vein thrombosis (DVT), you may worry about having another life-threatening clot. People who’ve had a DVT and can’t take blood-thinning medications have another option to prevent ...

BOTHELL, Wash.--(BUSINESS WIRE)--BTG plc (LSE: BTG), the global healthcare company, today announced the first patients outside of a clinical trial have been successfully implanted with the BTG Sentry ...